4TEEN4 Pharmaceuticals GmbH

4TEEN4 Pharmaceuticals GmbH develops diagnostic assays for biomarkers and monoclonal antibody therapies for critical care conditions. The Company conducts clinical research and publishes in the fields of cardiogenic shock, sepsis, and critical care medicine. 4TEEN4 Pharmaceuticals serves hospitals, intensive care units, and clinicians in Germany.